The ALDH3A2 gene gives your body instructions to break down certain fat related substances that form during normal metabolism. This gene plays an important role in protecting the skin and nervous system from buildup of these compounds. If it does not work properly, that buildup can cause Sjögren-Larsson syndrome, a condition linked to dry scaly skin, muscle stiffness, and developmental differences. People with this condition usually inherit a pathogenic ALDH3A2 variant from each parent.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or guide activities in the body. Some genes contain the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes take place, where they occur, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
ALDH3A2Gene function
What if the gene works
The ALDH3A2 gene helps cells turn fatty aldehydes into fatty acids. This supports normal fat processing and helps protect the skin and nervous system from buildup of certain fatty substances.
Risk
What if the gene does not work
When the ALDH3A2 gene does not work well, it causes Sjögren-Larsson syndrome, with dry scaly skin, leg stiffness, and developmental differences. Milder and more severe variants can affect how early features appear and how marked they are.
Treatment
What does that mean for your treatment
No ALDH3A2-specific treatment or drug-selection approach is currently established. Care is symptom-based rather than chosen by the ALDH3A2 gene result, although the ALDH3A2 gene is being studied as a drug target in Sjögren-Larsson syndrome, including treatments aimed at abnormal fat byproducts and itch-related pathways.
Conditions associated with ALDH3A2
Gene function
What if the gene works
In daily life, your cells constantly handle fats and small chemical byproducts that need careful cleanup. The ALDH3A2 gene helps with that cleanup by turning fatty aldehydes into fatty acids your body can safely use or process. Understanding how the ALDH3A2 gene helps break down fatty aldehydes makes its role in healthy cell function easier to picture.
The ALDH3A2 gene helps your cells convert fatty aldehydes into fatty acids. This is a key step in processing certain fats that come from food, normal cell activity, and the natural turnover of skin and other tissues.
Its protein clears away aldehydes, which are reactive chemical byproducts that can form when fats are processed or exposed to stress. This cleanup supports a steadier cell environment and helps limit unwanted chemical irritation inside cells.
By handling fatty aldehydes, the ALDH3A2 gene supports the normal balance of lipids, the fats that help build cell membranes. This helps cells keep their outer barrier stable and function smoothly in everyday conditions.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Many ALDH3A2 gene variants change the enzyme’s shape, stability, or how much of it a cell makes, leaving the protein with reduced activity or none at all. This is how ALDH3A2 gene variants can lead to buildup of fatty aldehydes inside cells. Milder variants may leave some activity, while more severe variants can nearly abolish it. Less remaining activity often links with earlier or more marked Sjögren-Larsson syndrome features, although this varies.
How variants are linked to conditions
Pathogenic variants in both copies of the ALDH3A2 gene cause Sjögren-Larsson syndrome, which is the main well-established ALDH3A2 gene condition link. This rare inherited condition is associated with dry, scaly skin from infancy, muscle stiffness that often affects walking, and developmental differences that can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALDH3A2, risk is mainly shaped by inheritance: a child usually develops the condition only if both parents pass on a changed copy of the gene. Family history and having parents who are blood relatives can increase the chance of this happening. Lifestyle factors are not known to meaningfully change this genetic risk.
Inheritance of ALDH3A2 variants
Variants in the ALDH3A2 gene linked to Sjögren-Larsson syndrome are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the ALDH3A2 gene from each parent. Parents who carry one altered copy are typically called carriers, and with each pregnancy they have a 25% chance of having a child with the condition, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child who inherits neither altered copy. Sons and daughters are affected equally in ALDH3A2 gene inheritance because the gene is on an autosome, not a sex chromosome.
What does my ALDH3A2 result mean for my family?
For families with an ALDH3A2-related condition, close relatives may also carry the changed gene even if they have no symptoms. Brothers and sisters may have the same condition or may be carriers, and other relatives on both sides of the family may also carry the change. This can matter for family planning, because carrier parents can pass the condition on to a child.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the ALDH3A2 gene, clinicians use genetic testing on a blood, saliva, or cheek swab sample. Genetic testing for the ALDH3A2 gene reads its DNA code to look for variants and can confirm a genetic diagnosis when symptoms or family history suggest Sjögren-Larsson syndrome.
When should I consider getting a genetic test?
Testing for the ALDH3A2 gene may be worth considering when someone has the typical pattern of Sjögren-Larsson syndrome, such as dry, scaly skin from infancy together with muscle stiffness in the legs and learning or vision problems. It can also help when this condition runs in the family or a relative already has an ALDH3A2 variant.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best interpreted together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment may work well for one person, cause more side effects in another, or seem to have less effect for someone else. Small inherited differences can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It focuses on links between genes and medications to help explain why the same treatment may not work in the same way for everyone. With many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ALDH3A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have questions about side effects, new symptoms, or how a treatment fits with your overall health, talk with your doctor or pharmacist.
History
Sjögren-Larsson syndrome, the condition linked to the ALDH3A2 gene, was first described in Sweden in the 1950s by Torsten Sjögren and Tage Larsson, who recognized a repeated inherited pattern in affected families. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect skin, movement, and learning features to a shared genetic cause. In the 1990s, researchers mapped the condition to chromosome 17 and then identified the ALDH3A2 gene as the key gene involved. From these first observations, research expanded steadily, allowing doctors to confirm the diagnosis with genetic testing rather than relying only on clinical signs. This history shaped today’s understanding of Sjögren-Larsson syndrome as a distinct inherited condition.